TECH

56.03

0.25% -0.14

Vorhandelsmarkt: 56.03

Bio Techne Corp (TECH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$56.17

Offen:

$56.41

24-Stunden-Volumen:

1.53M

Relative Volume:

0.57

Marktkapitalisierung:

$8.77B

Einnahmen:

$1.21B

Nettoeinkommen (Verlust:

$109.52M

KGV:

80.48

EPS:

0.6962

Netto-Cashflow:

$269.60M

1W Leistung:

+2.98%

1M Leistung:

+29.40%

6M Leistung:

-2.45%

1J Leistung:

+8.52%

1-Tages-Spanne:

$55.53

$56.96

1-Wochen-Bereich:

$51.97

$56.96

52-Wochen-Spanne:

$43.20

$72.16

Bio Techne Corp Stock (TECH) Company Profile

Firmenname

Bio Techne Corp

Sektor

Healthcare (1107)

Branche

Biotechnology (621)

Telefon

612-379-8854

Adresse

614 MCKINLEY PL N E, MINNEAPOLIS, MN

Mitarbeiter

3,100

Twitter

@biotechne

Nächster Verdiensttermin

2026-08-05

Neueste SEC-Einreichungen

TECH's Discussions on Twitter

Compare TECH vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TECH Bio Techne Corp	56.03	8.79B	1.21B	109.52M	269.60M	0.6962
VRTX Vertex Pharmaceuticals Inc	453.17	114.33B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	614.73	64.47B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	878.49	54.99B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	281.90	38.42B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	156.58	34.03B	742.00K	-1.37B	-1.07B	-7.0731

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-03	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2025-08-21	Hochstufung	Citigroup	Neutral → Buy
2025-07-22	Fortgesetzt	Stephens	Overweight
2025-07-09	Eingeleitet	TD Cowen	Buy
2025-05-30	Eingeleitet	Wells Fargo	Overweight
2025-04-09	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2025-03-18	Eingeleitet	Evercore ISI	Outperform
2025-02-19	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-05-22	Herabstufung	Citigroup	Buy → Neutral
2024-02-08	Eingeleitet	Scotiabank	Sector Outperform
2024-02-02	Herabstufung	Stifel	Buy → Hold
2023-12-07	Eingeleitet	UBS	Buy
2023-08-28	Eingeleitet	William Blair	Outperform
2023-01-10	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-12	Hochstufung	Citigroup	Neutral → Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Sector Perform
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2022-04-25	Herabstufung	Wells Fargo	Equal Weight → Underweight
2021-09-15	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-08	Hochstufung	Stephens	Equal-Weight → Overweight
2021-02-23	Hochstufung	Stifel	Hold → Buy
2021-01-25	Bestätigt	The Benchmark Company	Buy
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-09-30	Eingeleitet	Atlantic Equities	Overweight
2020-07-15	Herabstufung	Stephens	Overweight → Equal-Weight
2020-05-27	Herabstufung	Stifel	Buy → Hold
2020-05-14	Eingeleitet	The Benchmark Company	Buy
2020-01-08	Fortgesetzt	Stephens	Overweight
2020-01-08	Eingeleitet	Wells Fargo	Equal Weight
2020-01-07	Eingeleitet	Citigroup	Neutral
2019-11-15	Eingeleitet	Stifel	Buy
2019-07-02	Hochstufung	Janney	Neutral → Buy
2019-01-14	Hochstufung	Stephens	Equal-Weight → Overweight
2018-10-31	Herabstufung	Craig Hallum	Buy → Hold
2018-10-17	Eingeleitet	Goldman	Neutral
2018-06-15	Eingeleitet	Argus	Buy
2017-07-13	Eingeleitet	Wells Fargo	Market Perform
2017-02-09	Eingeleitet	Citigroup	Buy
2017-01-18	Eingeleitet	Deutsche Bank	Buy
2016-11-10	Fortgesetzt	Leerink Partners	Outperform
2015-01-21	Bestätigt	Robert W. Baird	Outperform
2013-09-20	Hochstufung	Robert W. Baird	Neutral → Outperform

Alle ansehen

Bio Techne Corp Aktie (TECH) Neueste Nachrichten

Jun 15, 2026

Bio-Techne (TECH) Stock Valuation After New Refeyn Bispecific Antibody Analysis Collaboration - Yahoo Finance

Jun 15, 2026

Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch

Jun 15, 2026

Bio-Techne (TECH) Gains 4% as Activist Investor Pushes for Strat - GuruFocus

Jun 15, 2026

Bio-Techne gains on report activist investor Ananym pushing for sale - Seeking Alpha

Jun 15, 2026

Bio-Techne stock rises as activist pushes for sale By Investing.com - Investing.com India

Jun 15, 2026

Activist Investor Ananym Urges Bio-Techne to Consider Selling - Bloomberg

Jun 15, 2026

Piper Sandler Launches Coverage on Bio-Techne (TECH), Prefers Patience on Sector Growth Drivers - Insider Monkey

Jun 15, 2026

Jun 13, 2026

Why is Techne (TECH) up 4.5% since last earnings report? - MSN

Jun 13, 2026

Is Bio-Techne Corporation (TECH) A Good Stock To Buy Now? - Yahoo Finance

Jun 13, 2026

Jun 11, 2026

Bio-Techne Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Jun 11, 2026

TECH Initiates Coverage On Bio-Techne -- Price Target Announced at $65 - GuruFocus

Jun 11, 2026

Piper Sandler initiates Bio-Techne stock with neutral rating By Investing.com - Investing.com Nigeria

Jun 11, 2026

Piper Sandler initiates Bio-Techne stock with neutral rating - Investing.com

Jun 11, 2026

Jun 10, 2026

Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch

Jun 10, 2026

Jun 08, 2026

New Bispecific Antibody Characterization Workflow Might Change The Case For Investing In Bio-Techne (TECH) - Yahoo Finance

Jun 08, 2026